Riddell Scott, MD
Dermatology · Austin, TXNPI 1881708139
Payments from drug & device makers
Across 66 payments — averaging $22.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$253
- Novartis$247
- Regeneron Healthcare Solutions, Inc.$194
- UCB, Inc.$160
- LEO Pharma Inc.$136
- AbbVie$117
- plus $367 from 11 others
What the payments were for
- Food & beverage$1,23984%
- Education$23616%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $253 |
| Novartis | 13 | $247 |
| Regeneron Healthcare Solutions, Inc. | 6 | $194 |
| UCB, Inc. | 6 | $160 |
| LEO Pharma Inc. | 6 | $136 |
| AbbVie | 6 | $117 |
| Sanofi | 5 | $102 |
| Galderma Laboratories, L.p. | 4 | $84 |
| Pfizer | 2 | $44 |
| Incyte Corporation | 1 | $25 |
| Dermavant Sciences, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Bristol Myers Squibb | 1 | $14 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,475 in reported general payments places this provider in the 30th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 20 | $1,532 |
| Imiquimod | 61 | $1,439 |
| Doxycycline Hyclate | 33 | $1,124 |
| Fluocinonide | 31 | $1,087 |
| Betamethasone Valerate | 25 | $845 |
| Ketoconazole | 65 | $823 |
| Metronidazole | 14 | $760 |
| Triamcinolone Acetonide | 96 | $732 |
| Clobetasol Propionate | 29 | $703 |
| Econazole Nitrate | 14 | $592 |
| Dapsone | 14 | $490 |
| ValacyclovirValacyclovir Hcl | 25 | $289 |
| Mupirocin | 26 | $177 |
| Hydroxyzine Hcl | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Austin
- Edward LainAustin$12M
- Janet DuboisAustin$3.5M
- Daniel CarrascoAustin$1.4M
- Dale SchaeferAustin$1M
- Heidi PratherAustin$543K
- Ali ShahbazAustin$413K
- David BushoreAustin$385K
- Blakely RichardsonAustin$279K
- Stephen TyringWebster$14.1M
- Mark LeeSan Antonio$10.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.